Search

Author/Creator Solez, K.

1. Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions. Issue 2 (February 2014)

Authors:
Haas, M.; Sis, B.; Racusen, L. C.; Solez, K.; Glotz, D.; Colvin, R. B.; Castro, M. C. R.; David, D. S. R.; David‐Neto, E.; Bagnasco, S. M.; Cendales, L. C.; Cornell, L. D.; Demetris, A. J.; Drachenberg, C. B.; Farver, C. F.; Farris, A. B.; Gibson, I. W.; Kraus, E.; Liapis, H.; Loupy, A.
Journal:
American journal of transplantation
Issue:
Volume 14:Issue 2(2014:Feb.)
Page Start:
272
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Issue 1 (28th December 2016)

Authors:
Loupy, A.; Haas, M.; Solez, K.; Racusen, L.; Glotz, D.; Seron, D.; Nankivell, B. J.; Colvin, R. B.; Afrouzian, M.; Akalin, E.; Alachkar, N.; Bagnasco, S.; Becker, J. U.; Cornell, L.; Drachenberg, C.; Dragun, D.; de Kort, H.; Gibson, I. W.; Kraus, E. S.; Lefaucheur, C.
Journal:
American journal of transplantation
Issue:
Volume 17:Issue 1(2017)
Page Start:
28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Issue 1 (January 2017)

Authors:
Loupy, A.; Haas, M.; Solez, K.; Racusen, L.; Glotz, D.; Seron, D.; Nankivell, B. J.; Colvin, R. B.; Afrouzian, M.; Akalin, E.; Alachkar, N.; Bagnasco, S.; Becker, J. U.; Cornell, L.; Drachenberg, C.; Dragun, D.; de Kort, H.; Gibson, I. W.; Kraus, E. S.; Lefaucheur, C.
Journal:
American journal of transplantation
Issue:
Volume 17:Issue 1(2017)
Page Start:
28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials. Issue 2 (21st January 2018)

Authors:
Haas, M.; Loupy, A.; Lefaucheur, C.; Roufosse, C.; Glotz, D.; Seron, D.; Nankivell, B. J.; Halloran, P. F.; Colvin, R. B.; Akalin, Enver; Alachkar, N.; Bagnasco, S.; Bouatou, Y.; Becker, J. U.; Cornell, L. D.; Duong van Huyen, J. P.; Gibson, I. W.; Kraus, Edward S.; Mannon, R. B.; Naesens, M.
Journal:
American journal of transplantation
Issue:
Volume 18:Issue 2(2018)
Page Start:
293
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The bridge between transplantation and regenerative medicine: Beginning a new Banff classification of tissue engineering pathology. Issue 2 (16th January 2018)

Authors:
Solez, K.; Fung, K. C.; Saliba, K. A.; Sheldon, V. L. C.; Petrosyan, A.; Perin, L.; Burdick, J. F.; Fissell, W. H.; Demetris, A. J.; Cornell, L. D.
Journal:
American journal of transplantation
Issue:
Volume 18:Issue 2(2018)
Page Start:
321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗